Rhenman & Partners Asset Management AB »

Ideaya Biosciences shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Ideaya Biosciences (IDYA) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Ideaya Biosciences

Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 20252M2.5M3M3.5M4M60k80k100k120k
Value ($)Share countHistorical IDYA position of Rhenman & Partners … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Ideaya Biosciences held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ideaya Biosciences by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.1M 82k 25.70
2024-09-30 $4.0M 128k 31.68
2024-06-30 $1.9M 54k 35.11

More positions owned by Rhenman & Partners Asset Management AB

Boston Scientific Corporation (BSX)
Eli Lilly & Co. (LLY)
Procept Biorobotics Corp (PRCT)
Intuitive Surgical Com New (ISRG)
Regeneron Pharmaceuticals (REGN)
UnitedHealth (UNH)
Inspire Med Sys (INSP)
Merck & Co (MRK)
EXACT Sciences Corporation (EXAS)
Tenet Healthcare Corp Com New (THC)
Gilead Sciences (GILD)
Abbvie (ABBV)
Cigna Corp (CI)
Medtronic SHS (MDT)
Vertex Pharmaceuticals Incorporated (VRTX)

View all positions for Rhenman & Partners Asset Management AB

Top funds holding Ideaya Biosciences

FMR
BlackRock
Henderson Group
Vanguard Group
Federated Investors
T. Rowe Price Associates
State Street Corporation
Logos Global Management
Deerfield Management Company
Capital Research Global Investors
Geode Capital Management
Pictet Asset Management Holding SA
Citadel Advisors
Goldman Sachs Group
Morgan Stanley

View all funds holding Ideaya Biosciences